Literature DB >> 15618214

Reduced local growth and spread but preserved pathogenicity of a DeltapurC Mycobacterium tuberculosis auxotrophic mutant in gamma interferon receptor-deficient mice after aerosol infection.

Najmeeyah Brown1, Muazzam Jacobs, Shreemanta K Parida, Tania Botha, Aldina Santos, Lizette Fick, Brigitte Gicquel, Mary Jackson, Valerie Quesniaux, Bernhard Ryffel.   

Abstract

We compared the growth levels and pathogenicities of the Mycobacterium tuberculosis MT103 clinical strain with those of the DeltapurC mutant strain MYC1551, which is auxotrophic for purine in wild-type and gamma interferon receptor (IFN-gammaR)-deficient mice. The DeltapurC strain MYC1551 grew initially in both wild-type and IFN-gammaR-deficient mice upon aerosol infection, but it grew much less than strain MT103 did. Despite the comparable bacterial burdens of the mice, IFN-gammaR-deficient mice succumbed to infection with DeltapurC strain MYC1551 from necrotic pneumonia within 6 weeks of those infected with MT103. In conclusion, the DeltapurC mutant MYC1551 displays reduced growth but retains pathogenicity. Therefore, the use of mutant strains of M. tuberculosis as live vaccines may not be recommended.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15618214      PMCID: PMC538938          DOI: 10.1128/IAI.73.1.666-670.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

Review 1.  Tuberculosis vaccine development: recent progress.

Authors:  I M Orme; D N McMurray; J T Belisle
Journal:  Trends Microbiol       Date:  2001-03       Impact factor: 17.079

2.  Persistence and protective efficacy of a Mycobacterium tuberculosis auxotroph vaccine.

Authors:  M Jackson; S W Phalen; M Lagranderie; D Ensergueix; P Chavarot; G Marchal; D N McMurray; B Gicquel; C Guilhot
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

3.  Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis.

Authors:  M K Hondalus; S Bardarov; R Russell; J Chan; W R Jacobs; B R Bloom
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

Review 4.  Erasing the world's slow stain: strategies to beat multidrug-resistant tuberculosis.

Authors:  Christopher Dye; Brian G Williams; Marcos A Espinal; Mario C Raviglione
Journal:  Science       Date:  2002-03-15       Impact factor: 47.728

Review 5.  Survival perspectives from the world's most successful pathogen, Mycobacterium tuberculosis.

Authors:  Suzanne M Hingley-Wilson; Vasan K Sambandamurthy; William R Jacobs
Journal:  Nat Immunol       Date:  2003-10       Impact factor: 25.606

Review 6.  Immunology of tuberculosis and implications in vaccine development.

Authors:  JoAnne L Flynn
Journal:  Tuberculosis (Edinb)       Date:  2004       Impact factor: 3.131

7.  Immune response in mice that lack the interferon-gamma receptor.

Authors:  S Huang; W Hendriks; A Althage; S Hemmi; H Bluethmann; R Kamijo; J Vilcek; R M Zinkernagel; M Aguet
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

8.  Multiple defects of immune cell function in mice with disrupted interferon-gamma genes.

Authors:  D K Dalton; S Pitts-Meek; S Keshav; I S Figari; A Bradley; T A Stewart
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

9.  Vaccine efficacy of a lysine auxotroph of Mycobacterium tuberculosis.

Authors:  Martin S Pavelka; Bing Chen; Cynthia L Kelley; Frank M Collins; William R Jacobs
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

10.  A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis.

Authors:  Vasan K Sambandamurthy; Xiaojuan Wang; Bing Chen; Robert G Russell; Steven Derrick; Frank M Collins; Sheldon L Morris; William R Jacobs
Journal:  Nat Med       Date:  2002-09-09       Impact factor: 53.440

View more
  4 in total

1.  The cGAS/STING Pathway Is Important for Dendritic Cell Activation but Is Not Essential to Induce Protective Immunity against Mycobacterium tuberculosis Infection.

Authors:  Fabio V Marinho; Sulayman Benmerzoug; Stephanie Rose; Priscila C Campos; João T Marques; André Báfica; Glen Barber; Bernhard Ryffel; Sergio C Oliveira; Valerie F J Quesniaux
Journal:  J Innate Immun       Date:  2018-05-23       Impact factor: 7.349

2.  Interferon γ and Tumor Necrosis Factor Are Not Essential Parameters of CD4+ T-Cell Responses for Vaccine Control of Tuberculosis.

Authors:  Mark T Orr; Hillarie Plessner Windish; Elyse A Beebe; David Argilla; Po-Wei D Huang; Valerie A Reese; Steven G Reed; Rhea N Coler
Journal:  J Infect Dis       Date:  2015-01-30       Impact factor: 5.226

Review 3.  Vaccines for tuberculosis: novel concepts and recent progress.

Authors:  T Mark Doherty; Peter Andersen
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

4.  Genomic Comparisons Reveal Microevolutionary Differences in Mycobacterium abscessus Subspecies.

Authors:  Joon L Tan; Kee P Ng; Chia S Ong; Yun F Ngeow
Journal:  Front Microbiol       Date:  2017-10-23       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.